What is Cagrilintide + Semaglutide Blend and its mechanism?

Cagrilintide + Semaglutide Blend combines two complementary metabolic pathways - Cagrilintide (amylin analog) and Semaglutide (GLP-1 agonist). Cagrilintide activates amylin receptors to delay gastric emptying and suppress glucagon, while Semaglutide activates GLP-1 receptors for enhanced insulin secretion and appetite regulation. This dual-pathway approach enables researchers to investigate synergistic metabolic effects beyond single-receptor activation.

What research applications does this blend support?

This blend excels in multi-pathway metabolic research, synergistic appetite regulation studies, combined incretin and amylin pathway investigations, glucose homeostasis research comparing dual vs single agonist effects, gastric emptying modulation studies, and comprehensive weight management mechanism research in laboratory models. Ideal for investigating complementary metabolic signaling pathways.

What purity standards does your blend meet?

Our Cagrilintide + Semaglutide Blend exceeds >98% purity verified by HPLC for both components. Each batch undergoes dual mass spectrometry confirmation (separate molecular weight verification for cagrilintide and semaglutide), ratio verification ensuring consistent blend composition, bioactivity testing for both amylin and GLP-1 receptor activation, endotoxin screening (<0.1 EU/mg), and comprehensive Certificate of Analysis documentation.

Can this blend be used in comparative studies with individual peptides?

Absolutely! Researchers commonly use this blend in head-to-head comparisons against cagrilintide alone, semaglutide alone, or other GLP-1 agonists to isolate synergistic effects. This comparative approach reveals whether dual amylin/GLP-1 activation provides additive or synergistic metabolic benefits versus single-pathway activation in controlled laboratory investigations.

How should this blend be stored and reconstituted?

Store lyophilized blend at -20°C in original sealed vials for 24+ months stability. Reconstitute with bacteriostatic water or sterile saline by adding solvent slowly down vial wall, then gently swirl (never shake) until completely dissolved at 1-5 mg/mL concentration. Refrigerate reconstituted solution at 2-8°C and use within 14 days. Avoid multiple freeze-thaw cycles to preserve both peptide components.

What makes this blend unique compared to single GLP-1 agonists?

Unlike single GLP-1 agonists (semaglutide, liraglutide), this blend adds amylin pathway activation through cagrilintide. Amylin receptor agonism provides complementary gastric emptying delay, enhanced satiety signaling, and glucagon suppression that differs mechanistically from GLP-1 effects. This dual mechanism enables investigation of incretin-amylin synergy that cannot be achieved with GLP-1 agonists alone.

What dosage variants are available and what is the pricing?

We offer 2 specification options: CS5 (5mg per 10-vial kit) and CS10 (10mg per 10-vial kit). Pricing: CS5 at $180/kit (1 kit), $170 (20+ kits), $160 (50+ kits). CS10 at $290/kit (1 kit), $280 (20+ kits), $270 (50+ kits). Bulk orders of 20+ kits receive 5-10% discount, and 50+ kits receive 10-15% savings. Contact via WhatsApp for custom quantity requirements.

How does the amylin component (cagrilintide) complement GLP-1 action?

Amylin and GLP-1 activate different receptor families with complementary metabolic effects. Amylin (via calcitonin receptor-like receptor) primarily delays gastric emptying and modulates central satiety circuits, while GLP-1 enhances insulin secretion and inhibits glucagon. Together, they create multi-pathway metabolic regulation - making this blend valuable for investigating receptor-specific vs synergistic contributions to metabolic homeostasis.

What bioactivity testing validates dual-pathway activation?

Beyond chemical purity (HPLC/mass spec), we perform dual bioassays: (1) Amylin receptor activation assays using cAMP response in receptor-expressing cells for cagrilintide component, and (2) GLP-1 receptor activation assays measuring insulin secretion or cAMP response for semaglutide component. This dual bioactivity testing ensures both pathways function as expected in research applications.

What shipping methods and documentation support international research?

We ship in lyophilized form with cold pack insulation in sealed packaging. The formulation remains stable at ambient temperature for short periods (up to 7 days). International delivery typically takes 10-14 days with tracking. Each batch includes comprehensive CoA with dual HPLC chromatograms (both peptides), dual mass spectrometry data, blend ratio verification, dual bioactivity results, endotoxin testing, batch number, and storage recommendations. Transfer to -20°C immediately upon receipt.

Home ProductsCagrilintide + Semaglutide Blend

Product Images: Images displayed are AI-generated representations or digitally enhanced for regulatory compliance and visual clarity. Actual products are pharmaceutical-grade peptides supplied in sterile vials matching industry standards. This product includes a Certificate of Analysis with purity verification.

CSB10

Cagrilintide + Semaglutide Blend

Q: Can this blend be used in comparative studies with individual peptides?

Absolutely! Researchers commonly use this blend in head-to-head comparisons against cagrilintide alone, semaglutide alone, or other GLP-1 agonists to isolate synergistic effects. This comparative approach reveals whether dual amylin/GLP-1 activation provides additive or synergistic metabolic benefits versus single-pathway activation in controlled laboratory investigations.

Q: How should this blend be stored and reconstituted?

Store lyophilized blend at -20°C in original sealed vials for 24+ months stability. Reconstitute with bacteriostatic water or sterile saline by adding solvent slowly down vial wall, then gently swirl (never shake) until completely dissolved at 1-5 mg/mL concentration. Refrigerate reconstituted solution at 2-8°C and use within 14 days. Avoid multiple freeze-thaw cycles to preserve both peptide components.

Q: What makes this blend unique compared to single GLP-1 agonists?

Unlike single GLP-1 agonists (semaglutide, liraglutide), this blend adds amylin pathway activation through cagrilintide. Amylin receptor agonism provides complementary gastric emptying delay, enhanced satiety signaling, and glucagon suppression that differs mechanistically from GLP-1 effects. This dual mechanism enables investigation of incretin-amylin synergy that cannot be achieved with GLP-1 agonists alone.

Q: What dosage variants are available and what is the pricing?

We offer 2 specification options: CS5 (5mg per 10-vial kit) and CS10 (10mg per 10-vial kit). Pricing: CS5 at $180/kit (1 kit), $170 (20+ kits), $160 (50+ kits). CS10 at $290/kit (1 kit), $280 (20+ kits), $270 (50+ kits). Bulk orders of 20+ kits receive 5-10% discount, and 50+ kits receive 10-15% savings. Contact via WhatsApp for custom quantity requirements.

Q: How does the amylin component (cagrilintide) complement GLP-1 action?

Amylin and GLP-1 activate different receptor families with complementary metabolic effects. Amylin (via calcitonin receptor-like receptor) primarily delays gastric emptying and modulates central satiety circuits, while GLP-1 enhances insulin secretion and inhibits glucagon. Together, they create multi-pathway metabolic regulation - making this blend valuable for investigating receptor-specific vs synergistic contributions to metabolic homeostasis.

Q: What bioactivity testing validates dual-pathway activation?

Beyond chemical purity (HPLC/mass spec), we perform dual bioassays: (1) Amylin receptor activation assays using cAMP response in receptor-expressing cells for cagrilintide component, and (2) GLP-1 receptor activation assays measuring insulin secretion or cAMP response for semaglutide component. This dual bioactivity testing ensures both pathways function as expected in research applications.

Q: What shipping methods and documentation support international research?

We ship in lyophilized form with cold pack insulation in sealed packaging. The formulation remains stable at ambient temperature for short periods (up to 7 days). International delivery typically takes 10-14 days with tracking. Each batch includes comprehensive CoA with dual HPLC chromatograms (both peptides), dual mass spectrometry data, blend ratio verification, dual bioactivity results, endotoxin testing, batch number, and storage recommendations. Transfer to -20°C immediately upon receipt.

For research and laboratory use only. Not for human consumption.

Dual-mechanism weight loss blend: Cagrilintide 5mg + Semaglutide 5mg for next-generation metabolic research

Blend Composition

Cagrilintide (Amylin Analogue)5mg

Semaglutide (GLP-1 Agonist)5mg

Pick Your Size

Select Quantity

Researcher·1 Kit

Volume pricing

Per-kit price drops as you scale

Add 1 more kit

Unlock Lab pricing at $315/kit

+$190

extra savings

Total Price

$410

Free Worldwide Shipping

No minimum order. Customs handled.

Express Delivery

7-14 Days

Ships To

190+ Countries

Customs Handled

99% Success Rate

Stealth Packaging

Cold-Chain

Lab-Grade Guarantee

If an independent HPLC assay of your lot comes back below the purity stated on our published Certificate of Analysis, we reship your order free. Verifiable, not a promise.

99.21% Purity Verified

HPLC / ESI-MS Tested

View Report

FOR RESEARCH PURPOSES ONLY. This product is strictly for laboratory and research use. Not for human consumption, medical treatment, or any clinical application. By ordering, you confirm you are a qualified researcher or represent a legitimate research institution.

Cagrilintide + Semaglutide Blend: Key Facts

Cagrilintide + Semaglutide Blend is a special blends research peptide supplied by LyzeLabs as a lyophilized reference standard, strictly for laboratory research use. It is available in 1 format starting at $410 per kit. Each batch is independently HPLC-verified at 99.21% purity by Janoshik Analytical, with the certificate of analysis published on the lab-results page and matched to the lot number printed on the vial.

Third-party verified batch

Compound	Cagrilintide + Semaglutide Blend
Research category	Special Blends
Available formats	10mg*10vials
Starting price	From $410 USD per kit
Purity	99.21% verified (third-party HPLC, Janoshik)
Test method	HPLC / ESI-MS
Certificate of analysis	Published online, matched to the vial lot number
Intended use	Laboratory research use only. Not for human consumption.
Handling	Supplied lyophilized, store per the stability guide

What Researchers Say

Dr. Vikram Patel

Netherlands

"Our metabolic research lab at a pharmaceutical research facility has been using this Cagrilintide + Semaglutide Blend for dual-pathway studies for 6 months. The synergistic effects on gastric emptying and insulin secretion are remarkable - we've compared it against individual cagrilintide and semaglutide to isolate the additive benefits. HPLC verification confirmed both components present at >98% purity with consistent blend ratio across 4 batches. We use CS5 and CS10 variants for dose-titration protocols. Delivery to Berlin takes 11 days with proper cold chain packaging. The dual bioactivity (amylin + GLP-1 receptor activation) makes this invaluable for comprehensive incretin-amylin research. Perfect for investigating multi-pathway metabolic regulation!"

2025-11-13

Ivy L.

United States

"Been buying for a few months. The COA-to-lot match is consistent, order to order."

2025-11-10

Zoe T.

Germany

"Their lab-results page made verification quick. Batch matched the vial."

2025-11-08

About This Product

Cagrilintide + Semaglutide Blend Research Guide

Two Metabolic Pathways, One Vial

The Cagrilintide + Semaglutide blend mirrors the investigational CagriSema combination in the research peptide supply. It pairs a long-acting amylin analog (Cagrilintide) with the reference GLP-1 receptor agonist (Semaglutide) so researchers can study the two mechanisms in combination using a single reconstitution rather than two separate vials.

The rationale is that amylin and GLP-1 act on distinct receptors through different downstream signaling pathways, yet converge on overlapping metabolic endpoints (appetite suppression, delayed gastric emptying, glucagon suppression). Combining them probes whether the two pathways are additive, synergistic, or independent in research models.

The Two Peptides

Cagrilintide: long-acting amylin receptor agonist. Binds the calcitonin receptor / RAMP complex in the area postrema and hypothalamus, producing appetite suppression through central satiety pathways distinct from GLP-1.
Semaglutide: long-acting GLP-1 receptor agonist. Triggers glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and acts on hypothalamic appetite centers through the well-characterized GLP-1 pathway.

Why the Combination Matters for Research

Distinct receptor targets: amylin and GLP-1 act through different receptor families, making their combined effects mechanistically independent rather than simply additive at one receptor
Complementary satiety pathways: amylin acts more on acute meal-level satiety, GLP-1 on both acute and sustained satiety
Comparative baselines: lets researchers probe what amylin adds to the GLP-1 baseline that [Semaglutide](/product/semaglutide) alone establishes
Protocol replication: matches the structure of published CagriSema-class investigational research

Research Applications

Dual metabolic pathway pharmacology studies
Comparative research against Semaglutide monotherapy baselines
Appetite and satiety research involving multiple receptor targets
Long-duration metabolic research where the combined signal is the study variable

Quality Standards

Purity: 99 percent plus verified independently for each peptide component (Janoshik Analytical)
Blend Ratio: documented on the per-batch Certificate of Analysis
Form: lyophilized powder, premixed in sterile vials
Storage: refrigerator for near-term use, minus 20 degrees Celsius long-term
Documentation: per-batch COAs for both components at /lab-results

For the mechanism context on Semaglutide and the broader metabolic peptide comparison, see the [Semaglutide Research Guide](/blog/semaglutide-research-guide) and [Retatrutide vs Tirzepatide vs Semaglutide](/blog/retatrutide-vs-tirzepatide-vs-semaglutide).

For research purposes only. Not for human consumption or therapeutic use.

Research Context for Cagrilintide + Semaglutide Blend

Multi-Peptide Blend Research Context

Research blends combine complementary peptides in defined ratios so that mechanistically distinct pathways can be probed in the same experimental session. The rationale for a blend over two separate vials is dose consistency, reduced inter-reconstitution variance, and matching ratios documented in the precedent literature.

Cagrilintide + Semaglutide Blend ships as a lyophilized research reagent through the LyzeLabs™ catalog in the Special Blends category, available as a single research-grade format. Every batch is independently verified by Janoshik Analytical, with the full HPLC chromatogram and mass spectrometry confirmation published on the LyzeLabs lab results page and matched to the lot number printed on your vial.

Related Research Guides

How to Read a Peptide Certificate of Analysis

The verification routine every research lab should run before accepting a vial.

How to Reconstitute a Research Peptide

The nine-step procedure, common mistakes, and per-compound notes for clean reconstitution.

Other Compounds in the Special Blends Category

GLOW Healing Blend (TB+BPC+GHK)

BPC-157 + TB-500 Blend

KLOW Healing Blend (TB+BPC+GHK+KPV)

Super Human Blend

Research Tools for This Compound

Frequently Asked Questions

Cagrilintide + Semaglutide Blend

$410